In today’s data-driven healthcare environment, patients are increasingly aware of their rights over how personal health information (PHI) is collected, shared, and reused. Nowhere is this more critical than in the fields of genomics, precision medicine, and secondary research, where the reuse of sensitive data must be governed with precision and transparency. However, static, form-based consent methods are no longer adequate to meet modern regulatory expectations or patient trust standards. As regulatory frameworks such as the General Data Protection Regulation (GDPR), California Consumer Privacy Act (CCPA), and HIPAA evolve, they demand more dynamic, granular, and enforceable approaches to consent tracking. GDPR, for example, mandates that consent be “freely given, specific, informed and unambiguous,” with clear auditability and revocation capabilities1 . Similarly, CCPA gives consumers the right to opt out of data sharing and requires systems to respond to consent changes in near real time. This whitepaper explores how Salesforce Health Cloud, when combined with tamper-proof technologies like blockchain, can deliver real-time, compliant, and verifiable consent lifecycle management. Salesforce offers data modeling, patient engagement, and automation capabilities, while blockchain provides immutable audit trails and decentralized trust. This integrated approach empowers healthcare organizations to not only comply with global privacy mandates but also reinforce patient agency and data transparency in every interaction. By adopting a composable, real-time strategy to consent governance, organizations can support future-ready research workflows, meet evolving regulatory demands, and strengthen the foundation of ethical data stewardship. 1. The New
Manish Gupta (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: